Tibet Pharmaceuticals (TBET) Reports Q1 EPS of $0.18 with $8.24 Million in Revenue
Tweet Send to a Friend
Tibet Pharmaceuticals (NASDAQ: TBET) reported Q1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
